Patient centricity, patient focus, patients first – words that are on everyone’s lips these days. But what do they really mean? Where does the patient voice fit in? And what do we stand to gain by really listening to patients?
An exploration into the value of the patient voice and the power it holds to transform outcomes. We explore:
What people mean when they talk about patient centricity
The benefits of listening to patients – for patients, Pharma and the healthcare system as a whole
The challenges to capturing the patient voice and how technology can help deliver it
How Pharma should evolve its practices to drive patient activation
Frontera London, part of the Frontera Group, is delighted to announce the additions of Emma Langley and Mark Frost to the senior leadership team. Frontera Group
Spanish Flu killed > 2% of the world, but accelerated healthcare for all. HOW is COVID-19 accelerating healthcare again and WHY does evidence say being an innovator matters? Frontera Group
Healthcare is critical. But healthcare will never be fixed to a point where we can say that it's done. Instead, it's about looking at things in new ways, exploring new ideas for changing behaviour to improve outcomes. For everyone. So, why don't more people try to do different? Frontera Group
Patient centricity, patient focus, patients first – words that are on everyone’s lips these days. But what do they really mean? Where does the patient voice fit in? And what do we stand to gain by really listening to patients? We spoke to patients, academics, Pharma, not-for-profit and industry professionals to find out the value of the patient voice. The power it holds to transform health outcomes, which benefits not only the healthcare system but also the pharmaceutical industry. Download our white paper and explore: What people mean when they talk about patient centricity The benefits of listening to patients – for patients, Pharma and the healthcare system as a whole The challenges to capturing the patient voice and how technology can help deliver it How Pharma should evolve its practices to drive patient activation Frontera Group